EUVIMEDOpdag EUVIMED
VergleichsstudieOpen access · CC BY-NC-ND 4.0

Transient Transfection of Rolling‐Circle Amplified DNA in Biomanufacturing‐Relevant Mammalian Cell Lines: A Comparison of Transfection Conditions for Optimal Protein Expression

Evelina Loghin, Erik Kvam iD, Lisa Lowery, Nathan Hudson, Jenny Keen, Brian Davis, Roger B Dodd, Christine Surrette, John Nelson

Biotechnology and Applied Biochemistry · 2025

DOI: 10.1002/bab.70100 ↗

At a glance

Vergleichsstudie in Biotechnology and Applied Biochemistry, 2025. Written by Evelina Loghin and 8 co-authors. Institution: GE HealthCare Technology & Innovation Center, Niskayuna, New York, USA. Major MEDLINE topics: Transfection, DNA, Nucleic Acid Amplification Techniques, Recombinant Proteins. Cited 1 times so far (Crossref); 30 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Defense Advanced Research Projects Agency.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Rolling‐circle amplification (RCA) is a completely synthetic and rapid mechanism for scaling‐up bulk DNA that eliminates requirements for large‐scale bacterial fermentation. Several reports have described the surprising ability of large unprocessed (hyperbranched) rolling circle‐amplified DNA (RCA DNA) to effectively transfect cultured cells; however, to our knowledge a comprehensive analysis of transfection conditions has not been conducted for this unique type of large synthetic DNA. Herein, we present comparative transfection data for two of the most common mammalian cell types used in biopharmaceutical manufacturing (suspension Chinese hamster ovary CHO cells and adherent HEK293 cells) and a panel of commercial transfection reagents that represent three general compositions (i.e., cationic lipid, cationic polymer, and complex blends). We show the efficiency of RCA DNA delivery is highly influenced by the transfection reagent and cell line, but expression patterns generally track with plasmid controls. Reagents comprising complex blends provide some of the best transfection results for RCA DNA, although additional reagent types work well. We also show it is possible to transfect two different RCA DNA products into CHO cells to produce monoclonal antibodies at high titer. We conclude that large and unique synthetic DNA produced by RCA is capable of being used in place of supercoiled plasmid for downstream transfection workflows.

Subjects

MeSH terms (MEDLINE)

TransfectionDNANucleic Acid Amplification TechniquesRecombinant ProteinsAnimalsCHO CellsHumansCricetulusHEK293 CellsCricetinae

Author keywords

antibody productionprotein expressionrolling‐circle amplificationsynthetic biologytransfection

Substances

DNARecombinant Proteins

Authors and institutions

  • GE HealthCare Technology & Innovation Center, Niskayuna, New York, USA.
  • AstraZeneca, R&D Biologics Engineering, The Discovery Centre, Cambridge, UK.

ORCID profiles: Erik Kvam

Funding

  • Defense Advanced Research Projects Agency

Cite

APA

Loghin, E., Kvam, E., Lowery, L., Hudson, N., Keen, J., Davis, B., Dodd, R. B., Surrette, C., & Nelson, J. (2025). Transient Transfection of Rolling‐Circle Amplified DNA in Biomanufacturing‐Relevant Mammalian Cell Lines: A Comparison of Transfection Conditions for Optimal Protein Expression. Biotechnology and Applied Biochemistry. https://doi.org/10.1002/bab.70100

Vancouver

Loghin E, Kvam E, Lowery L, Hudson N, Keen J, Davis B, et al. Transient Transfection of Rolling‐Circle Amplified DNA in Biomanufacturing‐Relevant Mammalian Cell Lines: A Comparison of Transfection Conditions for Optimal Protein Expression. Biotechnology and Applied Biochemistry. 2025. doi:10.1002/bab.70100

BibTeX
@article{Loghin2025,
  author = {Loghin, Evelina and Kvam, Erik and Lowery, Lisa and Hudson, Nathan and Keen, Jenny and Davis, Brian and Dodd, Roger B and Surrette, Christine and Nelson, John},
  title = {Transient Transfection of Rolling‐Circle Amplified DNA in Biomanufacturing‐Relevant Mammalian Cell Lines: A Comparison of Transfection Conditions for Optimal Protein Expression},
  journal = {Biotechnology and Applied Biochemistry},
  year = {2025},
  doi = {10.1002/bab.70100}
}
Start for free →